In a new whitepaper, cell and gene therapy experts in medical, operational, and regulatory come together to give insights from past trials. Read now.
Read More
Medpace was recently featured in a whitepaper “Winning at Your Drug Development Strategy: a Playbook for Emerging Biotechs” written by Labiotech – a leading digital media company covering the European Biotech industry. In the whitepaper, they discuss the importance of strategic planning in successful clinical development, what you need to be thinking about, and how to move forward.
Read More
In these upcoming webinars, experts from Medpace’s medical department, regulatory, and operational teams will provide insights and considerations on how to accelerate product development for COVID-19 and answer some frequently asked questions, trends they see emerging, and considerations for future development.
Read More
Medpace gathered experts in all areas of rare disease clinical research and created a three part webinar series. All three parts are now on-demand and available to watch.
Read More
We recognize the importance of the emerging role of precision medicine in the field of cardiovascular disease. To optimize support in the design and execution of cardiovascular clinical trials that employ a precision medicine strategy, we have initiated a Cardiovascular Precision Medicine Program (CVPMP).
Read More
This newly formed group within Medpace aims to support Sponsors who are under pressure from evolving and increased regulatory requirements.
Read More
In this three-part series of discussions with top experts in clinical development for rare disease and orphan indications, Medpace, along with industry partners, will address some of the key challenges, opportunities, and considerations for conducting research in this dynamic and complex area of research.
Read More
An in-depth look at infectious diseases including hematologic malignancies in immunocompromised patients and the unique challenges for clinical development.
Read More
Free to download, TrialPACE™ is specifically designed to keep patients engaged in the clinical trials they are enrolled in.
Read More
The 3rd European QA Conference is set to return November 6-8 this year to Dublin, one of Europe’s most popular destinations. Medpace will be participating in one of the sessions during the conference. Michael Baptist, Medpace’s Associate Director of Quality Assurance will be presenting on the role of technology in audits.
Read More